We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Violeta Petrova has been assisting clients through the H1B Visa process since 2022.

As of 2022, Violeta Petrova has succesfully submitted and recieved certification for 115 cases.

Violeta Petrova is located in New York, NY, and has represented 15 employers for the H1B Visa Process

148
Cases Handled
115
Cases Certified
77.70%
Approval

Cases Handled by Violeta Petrova

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-20325-922756 Certified - Withdrawn Software Developers Applications Pharmaceutical Preparation Manufacturing Roche Molecular Systems Inc 2022
I-200-20325-922753 Certified Software Developers Applications Pharmaceutical Preparation Manufacturing Roche Molecular Systems Inc 2021
I-200-20255-817477 Certified Software Developers Applications Pharmaceutical Preparation Manufacturing Roche Molecular Systems Inc 2020
I-200-20210-738459 Certified Software Developers Applications Pharmaceutical Preparation Manufacturing Roche Molecular Systems Inc 2020
I-200-20055-344566 Certified Software Developers Applications Pharmaceutical Preparation Manufacturing Roche Molecular Systems Inc 2020
I-200-21263-593203 Certified Computer Systems Analysts Research And Development In The Physical Engineering And Life Sciences Genentech Inc 2021
I-200-21054-094733 Certified - Withdrawn Computer Systems Analysts Research And Development In The Physical Engineering And Life Sciences Genentech Inc 2022
I-200-20017-262393 Certified Computer Systems Analysts Research And Development In The Physical Engineering And Life Sciences Genentech Inc 2020
I-200-21300-671304 Certified Financial Analysts Research And Development In The Physical Engineering And Life Sciences Genentech Inc 2022
I-200-20181-684537 Certified Financial Analysts Research And Development In The Physical Engineering And Life Sciences Genentech Inc 2020